Table 1.
Clinical characteristics of HGSOC cases from the HH cohort
| Characteristic | TLS low (n = 179) | TLS high (n = 63) | p |
|---|---|---|---|
| Age, years (%) | |||
| <70 | 135 (75.4) | 46 (73) | ns |
| >70 | 44 (24.6) | 17 (27) | |
| FIGO stage (%) | |||
| I | 9 (5) | 2 (3.2) | ns |
| II | 12 (6.7) | 7 (11.1) | |
| III | 107 (60) | 38 (60.3) | |
| IV | 45 (25.1) | 15 (23.9) | |
| unknown | 6 (3.3) | 1 (1.6) | |
| Residual disease (%) | |||
| optimal | 128(71.5) | 51(81) | ns |
| suboptimal | 40(22.3) | 9(14.3) | |
| unknown | 11 (6.1) | 3 (4.8) | |
| PFS (months) | |||
| median | 23 | 34.4 | 0.0194 |
| IQR | 13–44.8 | 18.6–∗ | |
| Relapse (%) | |||
| no | 79(44.1) | 44(69.8) | 0.00151 |
| yes | 85(47.5) | 17(27) | |
| unknown | 15(8.4) | 2 (3.2) | |